Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trialnvulsive status epilepticus in trial

Dalziel. Lancet 2019; 393(10186):2135-2145.

N = 233, 13 EDs in Australasia

Authors’ Conclusions:
Levetiracetam is not superior to phenytoin for second-line management of paediatric convulsive status epilepticus.